Through surveillance, risk assessment and targeted research, the Blood Safety Surveillance and Health Care Acquired Infections Division communicates, recommends, stimulates and manages the development and promotion of a national management/policy structure to reduce the risk of bloodborne pathogens (including community acquired bloodborne infections) and biological injuries due to blood transfusion and tissue and organ transplantation including xenotransplantation.
To share this page just click on the social network icon of your choice.